Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skull Deformity”

251 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 251 results

Not applicableEnded earlyNCT06140329
What this trial is testing

Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

Who this might be right for
Autosomal Dominant Optic AtrophyOptic Atrophy, Autosomal DominantOptic Atrophies, Hereditary+1 more
PYC Therapeutics 1
Not applicableStudy completedNCT05154175
What this trial is testing

Effectiveness of Ottobock Helmet Therapy in Infants With Plagiocephaly, Brachycephaly or Combination of Both

Who this might be right for
Plagiocephaly, PositionalPlagiocephaly, NonsynostoticBrachycephaly
Otto Bock France SNC 452
Not applicableUnknownNCT02370901
What this trial is testing

Cranial Orthotic Device Versus Repositioning Techniques for the Management of Plagiocephaly: the CRANIO Randomized Trial

Who this might be right for
Plagiocephaly, Nonsynostotic
Pat Ricalde,DDS, MD, FACS 226
Large-scale testing (Phase 3)Study completedNCT03293524
What this trial is testing

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

Who this might be right for
Leber Hereditary Optic Neuropathy
GenSight Biologics 98
Not applicableStudy completedNCT02510170
What this trial is testing

Fetal and Maternal Head Circumference During Pregnancy in Israeli Population

Who this might be right for
Maternal-Fetal RelationsMicrocephaly
Clalit Health Services 188
Not applicableLooking for participantsNCT02194816
What this trial is testing

Modifiable Variables in Parkinsonism (MVP)

Who this might be right for
Parkinson's DiseaseParkinsonismMSA - Multiple System Atrophy+6 more
Bastyr University 2,000
Testing effectiveness (Phase 2)Study completedNCT02064569
What this trial is testing

Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

Who this might be right for
Leber Hereditary Optic Neuropathy
GenSight Biologics 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131722
What this trial is testing

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

Who this might be right for
Neurofibromatosis Type IINF2
PRG Science & Technology Co., Ltd. 25
Not applicableStudy completedNCT00804102
What this trial is testing

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Who this might be right for
Retinitis PigmentosaMacula OffPrimary Open Angle Glaucoma+8 more
Okuvision GmbH 80
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Not applicableUnknownNCT00349024
What this trial is testing

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChordomaKidney Cancer+7 more
Children's Cancer and Leukaemia Group 50
Very early researchStudy completedNCT01880749
What this trial is testing

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomasMeningiomas
NYU Langone Health 5
Testing effectiveness (Phase 2)Study completedNCT01490476
What this trial is testing

Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients

Who this might be right for
Neurofibromatosis 2
Assistance Publique - Hôpitaux de Paris 10
Not applicableStudy completedNCT03406208
What this trial is testing

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Who this might be right for
NeurofibromatosesNeurofibromatosis 1Neurofibromatosis 2+1 more
Massachusetts General Hospital 228
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07708285
What this trial is testing

Luvometinib in Combination With Serplulimab for NF2-Related Tumors

Who this might be right for
NF2-related SchwannomatosisNF2Neurofibromatosis Type 2+2 more
Beijing Tiantan Hospital 30
Not applicableStudy completedNCT05891106
What this trial is testing

AONDA Therapeutic Indication Study I

Who this might be right for
Bullous KeratopathyCorneal ErosionEntropion+8 more
Alcon Research 55
Not applicableLooking for participantsNCT05848895
What this trial is testing

OPT-IN: Osteopathic Plagiocephaly Treatment for Infants and Neonates

Who this might be right for
Plagiocephaly, NonsynostoticPlagiocephaly, PositionalPlagiocephaly+1 more
Osteopathy's Promise to Children 122
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Early research (Phase 1)Study completedNCT02415153
What this trial is testing

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Who this might be right for
Neurofibromatosis Type 1Recurrent Childhood Brain Stem GliomaRecurrent Childhood Visual Pathway Glioma+2 more
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT01064505
What this trial is testing

Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

Who this might be right for
Optic AtrophyNon-arteritic Anterior Ischemic Optic Neuropathy
Quark Pharmaceuticals 48
Next Page